Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

922426

	registered interest
	date	12/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Re-employment
	house id	1
	legislature	25259 pref label House of Commons
	question text	Can the Secretary of State for Health and Social Care, how many staff made redundant by his Department between January and March 2017 have been reemployed by his Department on (a) permanent, (b) agency or (c) contractor contracts.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	152853
	answer	answer is ministerial correction date of answer 20/06/2018 answer text <p>No staff have been reemployed by the Department who previously left under compulsory or voluntary redundancy, between January and March 2017.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 20/06/2018 11:09:19 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4658 label Biography information for Alex Sobel

922991

	registered interest
	date	12/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Leukaemia: Ibrutinib
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government (1) what evidence NHS England considered, (2) which clinicians it consulted, and (3) which patient groups it consulted when deciding that ibrutinib should not be prescribed to people with chronic lymphocytic leukaemia who have been in remission for more than three years.
	tabling member printed	Lord Mendelsohn
	uin	HL8564
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>NHS England has advised that it develops treatment criteria for cancer and other high cost drugs to support implementation of National Institute for Health and Care Excellence (NICE) guidance and to ensure approved treatments are available as intended, with access funded consistently across the country. These criteria are developed by relevant expert clinical advisers, drawn from NHS England’s 42 Clinical Reference Groups (CRGs). These CRGs have been established to support clinical commissioning across the entire specialised commissioning portfolio.</p><p>In the case of NICE Technology Appraisal TA429 for ibrutinib in previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation, NICE issued the following statement on 8 June 2018:</p><p><strong> </strong>“Given the evidence that was considered by the NICE appraisal committee, we consider it reasonable for the guidance to be read as referring to those patients considered unsuitable for retreatment. Because unsuitability for retreatment is not defined in the guidance, we consider it appropriate for NHS England, as the commissioner, to take clinical advice in order to do so.”</p><p>NHS England took clinical advice in setting the specific treatment criteria linked to this appraisal and we are advised that the criteria were derived from the main study that had underpinned the NICE guidance and are consistent with guidance issued by the European Society for Medical Oncology last updated in June 2017. Between January 2017 and May 2018, nearly 1,000 patients were registered to receive treatment with ibrutinib in this indication. This is in line with NICE’s estimates that 700 adults per year would be eligible for treatment as a result of its guidance.</p><p>However, NHS England has further advised that it is more than willing to receive and review by the end of July, any further evidence that patients and clinicians wish to submit on this matter. The evidence will first be considered by NHS England’s Chemotherapy CRG, with advice and recommendations from this group then being submitted to the National Medical Director, Professor Steve Powis, for consideration.</p><p>During 2017/18, 1,193 Individual Funding Requests were considered by NHS England. An analysis of how may related to treatments for blood cancer has not been conducted.</p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL8561 HL8562 HL8563 question first answered 26/06/2018 12:13:53 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4286 label Biography information for Lord Mendelsohn

922973

	registered interest
	date	12/06/2018
	answering body	Foreign and Commonwealth Office
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	hansard heading	Burma: Armed Conflict
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government (1) what practical steps they are taking, and (2) what resources they are making available, to give effect to the UN doctrine of the Responsibility to Protect in response to reports of identity-based violence in Kachin; and how they are addressing any gaps in their approaches to predicting, preventing and responding to mass atrocities; to developing a cross-departmental strategy on atrocity prevention; and the integration of mass atrocity prevention into existing policy commitments and decision-making processes.
	tabling member printed	Lord Alton of Liverpool
	uin	HL8546
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>The Foreign Secretary spoke to Burma's State Counsellor Aung San Suu Kyi on 11 June and called for the Burmese military to exercise restraint and allow humanitarian access to those affected by recent fighting in Kachin. The UK's cross-Government approach to atrocity prevention includes the prediction and prevention of identity-based mass violence, alongside other forms of violence and instability, and is set within the Government's wider work on conflict prevention. Our early warning systems, such as our annual internal report on Countries at Risk of Instability, are complemented by shorter-term horizon-scanning tools, which assist policymakers in prioritising and directing Government engagement and activity on atrocity prevention and the Responsibility to Protect.</p> answering member printed Lord Ahmad of Wimbledon question first answered 26/06/2018 16:33:50 answering member 4210 label Biography information for Lord Ahmad of Wimbledon
	tabling member	738 label Biography information for Lord Alton of Liverpool

922989

	registered interest
	date	12/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how NHS England formulates approval criteria for drugs already approved by the National Institute for Health and Clinical Excellence; and how it involves (1) patients, and (2) clinicians in this process.
	tabling member printed	Lord Mendelsohn
	uin	HL8562
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>NHS England has advised that it develops treatment criteria for cancer and other high cost drugs to support implementation of National Institute for Health and Care Excellence (NICE) guidance and to ensure approved treatments are available as intended, with access funded consistently across the country. These criteria are developed by relevant expert clinical advisers, drawn from NHS England’s 42 Clinical Reference Groups (CRGs). These CRGs have been established to support clinical commissioning across the entire specialised commissioning portfolio.</p><p>In the case of NICE Technology Appraisal TA429 for ibrutinib in previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation, NICE issued the following statement on 8 June 2018:</p><p><strong> </strong>“Given the evidence that was considered by the NICE appraisal committee, we consider it reasonable for the guidance to be read as referring to those patients considered unsuitable for retreatment. Because unsuitability for retreatment is not defined in the guidance, we consider it appropriate for NHS England, as the commissioner, to take clinical advice in order to do so.”</p><p>NHS England took clinical advice in setting the specific treatment criteria linked to this appraisal and we are advised that the criteria were derived from the main study that had underpinned the NICE guidance and are consistent with guidance issued by the European Society for Medical Oncology last updated in June 2017. Between January 2017 and May 2018, nearly 1,000 patients were registered to receive treatment with ibrutinib in this indication. This is in line with NICE’s estimates that 700 adults per year would be eligible for treatment as a result of its guidance.</p><p>However, NHS England has further advised that it is more than willing to receive and review by the end of July, any further evidence that patients and clinicians wish to submit on this matter. The evidence will first be considered by NHS England’s Chemotherapy CRG, with advice and recommendations from this group then being submitted to the National Medical Director, Professor Steve Powis, for consideration.</p><p>During 2017/18, 1,193 Individual Funding Requests were considered by NHS England. An analysis of how may related to treatments for blood cancer has not been conducted.</p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL8561 HL8563 HL8564 question first answered 26/06/2018 12:13:53 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4286 label Biography information for Lord Mendelsohn

923006

	registered interest
	date	12/06/2018
	answering body	Department for Education
	answering dept id	60
	answering dept short name	Education
	answering dept sort name	Education
	hansard heading	Further Education
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many 19–24 year olds on first full Level 3 Further Education programmes were studying (1) full-time, and (2) part-time, in England in 2016–17.
	tabling member printed	Lord Smith of Clifton
	uin	HL8579
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>The information requested is not held centrally.</p><p>A total of 203,890 learners aged 19 to 24 years old participated in full Level 3 courses in the 2016-17 academic year.</p><p>Additional information on further education and skills participation is attached and also available from the ‘FE data library: further education and skills’ demographic tool at:</p><p><a href="https://www.gov.uk/government/statistical-data-sets/fe-data-library-further-education-and-skills" target="_blank">https://www.gov.uk/government/statistical-data-sets/fe-data-library-further-education-and-skills</a>.</p><p> </p> answering member printed Lord Agnew of Oulton question first answered 26/06/2018 16:16:32 answering member 4689 label Biography information for Lord Agnew of Oulton attachment 1 file name HL8579_FE_and_Skills_Participation_demographic.xls title HL8579_FE_and_Skills_Participation_demographic
	tabling member	3144 label Biography information for Lord Smith of Clifton

922990

	registered interest
	date	12/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Haematological Cancer
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many Individual Funding Requests have been submitted to the NHS for the treatment of blood cancer; and of those, how many requests were (1) successful, and (2) unsuccessful.
	tabling member printed	Lord Mendelsohn
	uin	HL8563
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>NHS England has advised that it develops treatment criteria for cancer and other high cost drugs to support implementation of National Institute for Health and Care Excellence (NICE) guidance and to ensure approved treatments are available as intended, with access funded consistently across the country. These criteria are developed by relevant expert clinical advisers, drawn from NHS England’s 42 Clinical Reference Groups (CRGs). These CRGs have been established to support clinical commissioning across the entire specialised commissioning portfolio.</p><p>In the case of NICE Technology Appraisal TA429 for ibrutinib in previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation, NICE issued the following statement on 8 June 2018:</p><p><strong> </strong>“Given the evidence that was considered by the NICE appraisal committee, we consider it reasonable for the guidance to be read as referring to those patients considered unsuitable for retreatment. Because unsuitability for retreatment is not defined in the guidance, we consider it appropriate for NHS England, as the commissioner, to take clinical advice in order to do so.”</p><p>NHS England took clinical advice in setting the specific treatment criteria linked to this appraisal and we are advised that the criteria were derived from the main study that had underpinned the NICE guidance and are consistent with guidance issued by the European Society for Medical Oncology last updated in June 2017. Between January 2017 and May 2018, nearly 1,000 patients were registered to receive treatment with ibrutinib in this indication. This is in line with NICE’s estimates that 700 adults per year would be eligible for treatment as a result of its guidance.</p><p>However, NHS England has further advised that it is more than willing to receive and review by the end of July, any further evidence that patients and clinicians wish to submit on this matter. The evidence will first be considered by NHS England’s Chemotherapy CRG, with advice and recommendations from this group then being submitted to the National Medical Director, Professor Steve Powis, for consideration.</p><p>During 2017/18, 1,193 Individual Funding Requests were considered by NHS England. An analysis of how may related to treatments for blood cancer has not been conducted.</p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL8561 HL8562 HL8564 question first answered 26/06/2018 12:13:53 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4286 label Biography information for Lord Mendelsohn

922964

	registered interest
	date	12/06/2018
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Low Pay
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many employees, excluding self-employed persons, in the UK, that are (1) male, and (2) female, earn less than the personal tax threshold.
	tabling member printed	Baroness Altmann
	uin	HL8537
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>Estimates of the number of individuals with total employee earnings less than the Income Tax Personal Allowance across all of their jobs are shown in the table below. The table relates to the 2016-17 tax year when the Personal Allowance was £11,000.</p><p> </p><p>The figures are for people employed and taxed through Pay As You Earn (PAYE) Income Tax. Individuals included in the table may have had more than one job in the year, and their total earnt income from all PAYE employment was below the Personal Allowance.</p><p> </p><table><tbody><tr><td colspan="2"><p>Individuals with total employee earnings less than the Income Tax Personal Allowance from all jobs, 2016-17 tax year (millions)</p></td></tr><tr><td><p>Male</p></td><td><p>4.72</p></td></tr><tr><td><p>Female</p></td><td><p>6.28</p></td></tr><tr><td><p>All</p></td><td><p>11.00</p></td></tr></tbody></table><p> </p><p> </p><p>Notes</p><p>Based on Pay As You Earn data. The earnings definition used is the same as used in the publication, <em>UK Real Time Information, Experimental Statistics</em>. See:</p><p><a href="https://www.gov.uk/government/statistics/uk-real-time-information-experimental-statistics" target="_blank">https://www.gov.uk/government/statistics/uk-real-time-information-experimental-statistics</a></p><p> </p><p> </p> answering member printed Lord Bates question first answered 26/06/2018 12:55:05 answering member 1091 label Biography information for Lord Bates
	tabling member	4533 label Biography information for Baroness Altmann

922967

	registered interest
	date	12/06/2018
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Bereavement Benefits
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many families with children received either Bereavement Benefit or Bereavement Support Payments in the fiscal years (1) 2013–2014, (2) 2014–2015, (3) 2015–2016, and (4) 2016–2017.
	tabling member printed	Baroness Altmann
	uin	HL8540
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>The Benefit Expenditure and Caseload Tables are published by the department after each fiscal event and contain outturn and forecast expenditure for all Bereavement Related Benefits including Widow’s Pension (WP), Widowed Mother’s Allowance (WMA), Bereavement Allowance (BA), Widowed Parent’s Allowance (WPA) and Bereavement Support Payment (BSP). Table 1 shows expenditure on Bereavement Related Benefits for the requested years from the latest release of these tables published after Spring Statement 2018. Table 2 shows forecast expenditure on Bereavement Support Payments, also from the same source.</p><p> </p><p>Table 1: Outturn Expenditure, £m 2018/19 prices</p><table><tbody><tr><td><p> </p></td><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>Bereavement Related Benefits</p></td><td><p>629</p></td><td><p>607</p></td><td><p>601</p></td><td><p>576</p></td></tr></tbody></table><p> </p><p>Table 2: Forecast Expenditure, £m, 2018/19 prices</p><table><tbody><tr><td><p> </p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>Bereavement Support Payment</p></td><td><p>115</p></td><td><p>199</p></td><td><p>206</p></td><td><p>203</p></td><td><p>198</p></td><td><p>195</p></td></tr></tbody></table><p> </p><p> </p><p>The department publishes caseload information on Bereavement Benefits and Widow’s Benefits recipients on on-line via Stat Xplore. These can be broken down by benefit type to show which claims have dependent children. Table 3 below shows caseload data from November of the requested years from Stat Xplore. The caseload is the number of claims in payment during the month in question.</p><p> </p><p>Table 3: Caseload</p><table><tbody><tr><td colspan="2"><p> </p></td><td><p>Nov-13</p></td><td><p>Nov-14</p></td><td><p>Nov-15</p></td><td><p>Nov-16</p></td></tr><tr><td rowspan="2"><p>Caseload</p></td><td><p>WMA or WPA with dependent children</p></td><td><p>46,300</p></td><td><p>45,300</p></td><td><p>44,200</p></td><td><p>43,100</p></td></tr><tr><td><p>WP, BA or WMA/WPA without dependent children</p></td><td><p>50,100</p></td><td><p>47,700</p></td><td><p>46,200</p></td><td><p>45,700</p></td></tr></tbody></table><p> </p><p>The forecast volume of claimants for Bereavement Support Payment, broken down by whether the claim is Standard Rate or Higher Rate is shown in Table 4. Claimants with dependent children and entitled to Child Benefit, or who were pregnant, when their husband, wife or civil partner died will get the higher rate. These forecasts are consistent with the caseload forecasts published in the Spring Statement 2018 Benefit Expenditure and Caseload Tables, and represent average caseloads over the full financial year.</p><p> </p><p>Table 4: Bereavement Support Payment Forecast Caseload</p><table><tbody><tr><td><p> </p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>Caseload - Standard Rate</p></td><td><p>19,000</p></td><td><p>49,000</p></td><td><p>53,000</p></td><td><p>53,000</p></td><td><p>54,000</p></td><td><p>53,000</p></td></tr><tr><td><p>Caseload - Higher Rate</p></td><td><p>3,000</p></td><td><p>8,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td></tr></tbody></table> answering member printed Baroness Buscombe grouped question UIN HL8538 HL8539 HL8541 HL8542 HL8589 question first answered 26/06/2018 14:48:47 answering member 3349 label Biography information for Baroness Buscombe
	tabling member	4533 label Biography information for Baroness Altmann

922968

	registered interest
	date	12/06/2018
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Bereavement Support Payment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many families with children they estimate will receive Bereavement Support Payments in the fiscal years (1) 2017–2018, (2) 2018–2019, (3) 2019–2020, (4) 2020–2021, (5) 2021–2022, and (6) 2022–2023.
	tabling member printed	Baroness Altmann
	uin	HL8541
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>The Benefit Expenditure and Caseload Tables are published by the department after each fiscal event and contain outturn and forecast expenditure for all Bereavement Related Benefits including Widow’s Pension (WP), Widowed Mother’s Allowance (WMA), Bereavement Allowance (BA), Widowed Parent’s Allowance (WPA) and Bereavement Support Payment (BSP). Table 1 shows expenditure on Bereavement Related Benefits for the requested years from the latest release of these tables published after Spring Statement 2018. Table 2 shows forecast expenditure on Bereavement Support Payments, also from the same source.</p><p> </p><p>Table 1: Outturn Expenditure, £m 2018/19 prices</p><table><tbody><tr><td><p> </p></td><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>Bereavement Related Benefits</p></td><td><p>629</p></td><td><p>607</p></td><td><p>601</p></td><td><p>576</p></td></tr></tbody></table><p> </p><p>Table 2: Forecast Expenditure, £m, 2018/19 prices</p><table><tbody><tr><td><p> </p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>Bereavement Support Payment</p></td><td><p>115</p></td><td><p>199</p></td><td><p>206</p></td><td><p>203</p></td><td><p>198</p></td><td><p>195</p></td></tr></tbody></table><p> </p><p> </p><p>The department publishes caseload information on Bereavement Benefits and Widow’s Benefits recipients on on-line via Stat Xplore. These can be broken down by benefit type to show which claims have dependent children. Table 3 below shows caseload data from November of the requested years from Stat Xplore. The caseload is the number of claims in payment during the month in question.</p><p> </p><p>Table 3: Caseload</p><table><tbody><tr><td colspan="2"><p> </p></td><td><p>Nov-13</p></td><td><p>Nov-14</p></td><td><p>Nov-15</p></td><td><p>Nov-16</p></td></tr><tr><td rowspan="2"><p>Caseload</p></td><td><p>WMA or WPA with dependent children</p></td><td><p>46,300</p></td><td><p>45,300</p></td><td><p>44,200</p></td><td><p>43,100</p></td></tr><tr><td><p>WP, BA or WMA/WPA without dependent children</p></td><td><p>50,100</p></td><td><p>47,700</p></td><td><p>46,200</p></td><td><p>45,700</p></td></tr></tbody></table><p> </p><p>The forecast volume of claimants for Bereavement Support Payment, broken down by whether the claim is Standard Rate or Higher Rate is shown in Table 4. Claimants with dependent children and entitled to Child Benefit, or who were pregnant, when their husband, wife or civil partner died will get the higher rate. These forecasts are consistent with the caseload forecasts published in the Spring Statement 2018 Benefit Expenditure and Caseload Tables, and represent average caseloads over the full financial year.</p><p> </p><p>Table 4: Bereavement Support Payment Forecast Caseload</p><table><tbody><tr><td><p> </p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>Caseload - Standard Rate</p></td><td><p>19,000</p></td><td><p>49,000</p></td><td><p>53,000</p></td><td><p>53,000</p></td><td><p>54,000</p></td><td><p>53,000</p></td></tr><tr><td><p>Caseload - Higher Rate</p></td><td><p>3,000</p></td><td><p>8,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td></tr></tbody></table> answering member printed Baroness Buscombe grouped question UIN HL8538 HL8539 HL8540 HL8542 HL8589 question first answered 26/06/2018 14:48:48 answering member 3349 label Biography information for Baroness Buscombe
	tabling member	4533 label Biography information for Baroness Altmann

922969

	registered interest
	date	12/06/2018
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Bereavement Benefits
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how many people without children in full-time education received Bereavement Benefit in the fiscal years (1) 2013–2014, (2) 2014–2015, (3) 2015–2016, and (4) 2016–2017.
	tabling member printed	Baroness Altmann
	uin	HL8542
	answer	answer is ministerial correction date of answer 26/06/2018 answer text <p>The Benefit Expenditure and Caseload Tables are published by the department after each fiscal event and contain outturn and forecast expenditure for all Bereavement Related Benefits including Widow’s Pension (WP), Widowed Mother’s Allowance (WMA), Bereavement Allowance (BA), Widowed Parent’s Allowance (WPA) and Bereavement Support Payment (BSP). Table 1 shows expenditure on Bereavement Related Benefits for the requested years from the latest release of these tables published after Spring Statement 2018. Table 2 shows forecast expenditure on Bereavement Support Payments, also from the same source.</p><p> </p><p>Table 1: Outturn Expenditure, £m 2018/19 prices</p><table><tbody><tr><td><p> </p></td><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>Bereavement Related Benefits</p></td><td><p>629</p></td><td><p>607</p></td><td><p>601</p></td><td><p>576</p></td></tr></tbody></table><p> </p><p>Table 2: Forecast Expenditure, £m, 2018/19 prices</p><table><tbody><tr><td><p> </p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>Bereavement Support Payment</p></td><td><p>115</p></td><td><p>199</p></td><td><p>206</p></td><td><p>203</p></td><td><p>198</p></td><td><p>195</p></td></tr></tbody></table><p> </p><p> </p><p>The department publishes caseload information on Bereavement Benefits and Widow’s Benefits recipients on on-line via Stat Xplore. These can be broken down by benefit type to show which claims have dependent children. Table 3 below shows caseload data from November of the requested years from Stat Xplore. The caseload is the number of claims in payment during the month in question.</p><p> </p><p>Table 3: Caseload</p><table><tbody><tr><td colspan="2"><p> </p></td><td><p>Nov-13</p></td><td><p>Nov-14</p></td><td><p>Nov-15</p></td><td><p>Nov-16</p></td></tr><tr><td rowspan="2"><p>Caseload</p></td><td><p>WMA or WPA with dependent children</p></td><td><p>46,300</p></td><td><p>45,300</p></td><td><p>44,200</p></td><td><p>43,100</p></td></tr><tr><td><p>WP, BA or WMA/WPA without dependent children</p></td><td><p>50,100</p></td><td><p>47,700</p></td><td><p>46,200</p></td><td><p>45,700</p></td></tr></tbody></table><p> </p><p>The forecast volume of claimants for Bereavement Support Payment, broken down by whether the claim is Standard Rate or Higher Rate is shown in Table 4. Claimants with dependent children and entitled to Child Benefit, or who were pregnant, when their husband, wife or civil partner died will get the higher rate. These forecasts are consistent with the caseload forecasts published in the Spring Statement 2018 Benefit Expenditure and Caseload Tables, and represent average caseloads over the full financial year.</p><p> </p><p>Table 4: Bereavement Support Payment Forecast Caseload</p><table><tbody><tr><td><p> </p></td><td><p>2017/18</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td></tr><tr><td><p>Caseload - Standard Rate</p></td><td><p>19,000</p></td><td><p>49,000</p></td><td><p>53,000</p></td><td><p>53,000</p></td><td><p>54,000</p></td><td><p>53,000</p></td></tr><tr><td><p>Caseload - Higher Rate</p></td><td><p>3,000</p></td><td><p>8,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td><td><p>9,000</p></td></tr></tbody></table> answering member printed Baroness Buscombe grouped question UIN HL8538 HL8539 HL8540 HL8541 HL8589 question first answered 26/06/2018 14:48:48 answering member 3349 label Biography information for Baroness Buscombe
	tabling member	4533 label Biography information for Baroness Altmann